BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12086892)

  • 1. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
    Eriksson A; Cao R; Pawliuk R; Berg SM; Tsang M; Zhou D; Fleet C; Tritsaris K; Dissing S; Leboulch P; Cao Y
    Cancer Cell; 2002 Feb; 1(1):99-108. PubMed ID: 12086892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
    J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
    Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
    Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
    Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
    Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
    Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.
    Ahmed A; Dunk C; Ahmad S; Khaliq A
    Placenta; 2000; 21 Suppl A():S16-24. PubMed ID: 10831117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E; Schiller P; Cao Y; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vascular endothelial growth factor and placental growth factor in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice.
    Molinas CR; Campo R; Dewerchin M; Eriksson U; Carmeliet P; Koninckx PR
    Fertil Steril; 2003 Sep; 80 Suppl 2():803-11. PubMed ID: 14505757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
    Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth.
    Ratajczak MZ; Ratajczak J; Machalinski B; Majka M; Marlicz W; Carter A; Pietrzkowski Z; Gewirtz AM
    Br J Haematol; 1998 Dec; 103(4):969-79. PubMed ID: 9886308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.
    Donnini S; Machein MR; Plate KH; Weich HA
    J Pathol; 1999 Sep; 189(1):66-71. PubMed ID: 10451490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
    Clauss M; Weich H; Breier G; Knies U; Röckl W; Waltenberger J; Risau W
    J Biol Chem; 1996 Jul; 271(30):17629-34. PubMed ID: 8663424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.
    Lacal PM; Failla CM; Pagani E; Odorisio T; Schietroma C; Falcinelli S; Zambruno G; D'Atri S
    J Invest Dermatol; 2000 Dec; 115(6):1000-7. PubMed ID: 11121133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of VEGF-induced angiogenesis by preventing VEGF secretion.
    Björndahl M; Cao R; Eriksson A; Cao Y
    Circ Res; 2004 Jun; 94(11):1443-50. PubMed ID: 15192038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of choroidal and corneal pathologic neovascularization by Plgf1-de gene transfer.
    Tarallo V; Bogdanovich S; Hirano Y; Tudisco L; Zentilin L; Giacca M; Ambati J; De Falco S
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):7989-96. PubMed ID: 23139276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
    Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
    Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
    Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
    Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution.
    Iyer S; Leonidas DD; Swaminathan GJ; Maglione D; Battisti M; Tucci M; Persico MG; Acharya KR
    J Biol Chem; 2001 Apr; 276(15):12153-61. PubMed ID: 11069911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.